194 related articles for article (PubMed ID: 15942711)
1. A study of histopathological assessment criteria for assessing malignancy of gastrointestinal stromal tumor, from a clinical standpoint.
Yokoi K; Tanaka N; Shoji K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Yamashita K; Ohaki Y; Tajiri T
J Gastroenterol; 2005 May; 40(5):467-73. PubMed ID: 15942711
[TBL] [Abstract][Full Text] [Related]
2. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of gastrointestinal stromal tumors.
Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
5. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
9. Prognostic assessment of gastrointestinal stromal tumor.
Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
[TBL] [Abstract][Full Text] [Related]
10. The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: a cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors.
Elliott DD; Fanning CV; Caraway NP
Cancer; 2006 Feb; 108(1):49-55. PubMed ID: 16130141
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach.
Okubo K; Yamao K; Nakamura T; Tajika M; Sawaki A; Hara K; Kawai H; Yamamura Y; Mochizuki Y; Koshikawa T; Inada K
J Gastroenterol; 2004 Aug; 39(8):747-53. PubMed ID: 15338368
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of gastrointestinal stromal tumor: a report of 29 patients].
Qin HD; Zhang DW; Yang WL
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):139-41. PubMed ID: 16555155
[TBL] [Abstract][Full Text] [Related]
13. Biological analysis of gastrointestinal stromal tumors.
Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
[TBL] [Abstract][Full Text] [Related]
14. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
Hassan I; You YN; Dozois EJ; Shayyan R; Smyrk TC; Okuno SH; Donohue JH
Dis Colon Rectum; 2006 May; 49(5):609-15. PubMed ID: 16552495
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 60 cases with malignant gastrointestinal stromal tumors].
Lin F; Cao J; Xia JT; Huang CM; DU H; Chen GQ; Wen MJ; Dai LH; Lai YY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):409-11. PubMed ID: 17043962
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of gastrointestinal stromal tumors: a study of 96 patients].
Lou YL; Chen H; Zhang XL; Zhan ZL
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):437-9. PubMed ID: 15355652
[TBL] [Abstract][Full Text] [Related]
17. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.
Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ
J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224
[TBL] [Abstract][Full Text] [Related]
19. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
